Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) EBT (2016 - 2025)

Apyx Medical (APYX) has disclosed EBT for 15 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT fell 105.41% year-over-year to -$1.1 million, compared with a TTM value of -$10.8 million through Dec 2025, down 541.34%, and an annual FY2025 reading of -$10.8 million, down 541.34% over the prior year.
  • EBT was -$1.1 million for Q4 2025 at Apyx Medical, up from -$1.9 million in the prior quarter.
  • Across five years, EBT topped out at $21.2 million in Q4 2024 and bottomed at -$9.5 million in Q4 2023.
  • Average EBT over 5 years is -$3.4 million, with a median of -$4.8 million recorded in 2021.
  • Peak annual rise in EBT hit 322.21% in 2024, while the deepest fall reached 585.83% in 2024.
  • Year by year, EBT stood at -$1.9 million in 2021, then plummeted by 215.25% to -$5.9 million in 2022, then plummeted by 61.26% to -$9.5 million in 2023, then surged by 322.21% to $21.2 million in 2024, then crashed by 105.41% to -$1.1 million in 2025.
  • Business Quant data shows EBT for APYX at -$1.1 million in Q4 2025, -$1.9 million in Q3 2025, and -$3.7 million in Q2 2025.